A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc.
Nimbus Therapeutics
University of Pittsburgh
Marengo Therapeutics, Inc.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Blokhin's Russian Cancer Research Center